Paper17045367
A review of human vaccine research and development: malaria.
Girard MP and 3 others. Vaccine, 2007. Cited by 100 papers, by iCite.
Cite this record
ConductScience Library. A review of human vaccine research and development: malaria. Papers, record 17045367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17045367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Design | Major topic |
| Malaria Vaccines | Major topic |
| Malaria, Falciparum | Major topic |
| Plasmodium falciparum | Major topic |
| Research Design | Major topic |
| Animals | |
| Antigens, Protozoan | |
| Humans |
Source PubMed
Cited by54
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 100 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40134119 | Gaps in vaccine clinical trials in Africa: A mixed scoping review and bibliometric analysis before, during, and post- COVID-19 pandemic. | Hum Vaccin Immunother | 2025 | https://conductscience.org/library/papers/40134119 | PubMed |
| 37511330 | Construction, Expression, and Evaluation of the Naturally Acquired Humoral Immune Response against Plasmodium vivax RMC-1, a Multistage Chimeric Protein. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37511330 | PubMed |
| 35293561 | Plasmodium falciparum merozoite surface protein 3 as a vaccine candidate: a brief review. | Rev Inst Med Trop Sao Paulo | 2022 | https://conductscience.org/library/papers/35293561 | PubMed |
| 34914066 | A Fast-Track Phenotypic Characterization of Plasmodium falciparum Vaccine Antigens through Lyse-Reseal Erythrocytes Mediated Delivery (LyRED) of RNA Interference for Targeted Translational Repression. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/34914066 | PubMed |
| 34358177 | Combating Human Viral Diseases: Will Plant-Based Vaccines Be the Answer? | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34358177 | PubMed |
| 33737844 | Towards Eradication of Malaria: Is the WHO's RTS,S/AS01 Vaccination Effective Enough? | Risk Manag Healthc Policy | 2021 | https://conductscience.org/library/papers/33737844 | PubMed |
| 33032613 | Age-dependent carriage of alleles and haplotypes of Plasmodium falciparum sera5, eba-175, and csp in a region of intense malaria transmission in Uganda. | Malar J | 2020 | https://conductscience.org/library/papers/33032613 | PubMed |
| 32870446 | An AMA1/MSP119 Adjuvanted Malaria Transplastomic Plant-Based Vaccine Induces Immune Responses in Test Animals. | Mol Biotechnol | 2020 | https://conductscience.org/library/papers/32870446 | PubMed |
| 31025102 | Immunological evaluation of two novel engineered Plasmodium vivax circumsporozoite proteins formulated with different human-compatible vaccine adjuvants in C57BL/6 mice. | Med Microbiol Immunol | 2019 | https://conductscience.org/library/papers/31025102 | PubMed |
| 29211303 | Evaluating antidisease immunity to malaria and implications for vaccine design. | Immunology | 2018 | https://conductscience.org/library/papers/29211303 | PubMed |
| 28272979 | Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan. | Hum Vaccin Immunother | 2017 | https://conductscience.org/library/papers/28272979 | PubMed |
| 27487171 | Production of Plasmodium vivax enolase in Escherichia coli and its protective properties. | Hum Vaccin Immunother | 2016 | https://conductscience.org/library/papers/27487171 | PubMed |
| 26856829 | Assessment of the Worldwide Antimalarial Resistance Network Standardized Procedure for In Vitro Malaria Drug Sensitivity Testing Using SYBR Green Assay for Field Samples with Various Initial Parasitemia Levels. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/26856829 | PubMed |
| 26471813 | Antibodies to Plasmodium falciparum merozoite surface protein-1p19 malaria vaccine candidate induce antibody-dependent respiratory burst in human neutrophils. | Malar J | 2015 | https://conductscience.org/library/papers/26471813 | PubMed |
| 26330866 | Computational Study of Quinolone Derivatives to Improve their Therapeutic Index as Anti-malaria Agents: QSAR and QSTR. | Iran J Pharm Res | 2015 | https://conductscience.org/library/papers/26330866 | PubMed |
| 25563798 | Calibration of an intrahost malaria model and parameter ensemble evaluation of a pre-erythrocytic vaccine. | Malar J | 2015 | https://conductscience.org/library/papers/25563798 | PubMed |
| 24615122 | Early phase clinical trials with human immunodeficiency virus-1 and malaria vectored vaccines in The Gambia: frontline challenges in study design and implementation. | Am J Trop Med Hyg | 2014 | https://conductscience.org/library/papers/24615122 | PubMed |
| 23710439 | Malaria vaccine adjuvants: latest update and challenges in preclinical and clinical research. | Biomed Res Int | 2013 | https://conductscience.org/library/papers/23710439 | PubMed |
| 23496910 | Experience and challenges from clinical trials with malaria vaccines in Africa. | Malar J | 2013 | https://conductscience.org/library/papers/23496910 | PubMed |
| 22911156 | Overview of plant-made vaccine antigens against malaria. | J Biomed Biotechnol | 2012 | https://conductscience.org/library/papers/22911156 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17045367
GET https://conductscience.org/api/papers/v1/17045367/cited_by?page=2